Literature DB >> 35325594

Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer.

Rodrigo Nalio Ramos1, Yoann Missolo-Koussou1, Yohan Gerber-Ferder1, Christian P Bromley2, Mattia Bugatti3, Nicolas Gonzalo Núñez1, Jimena Tosello Boari1, Wilfrid Richer1, Laurie Menger4, Jordan Denizeau1, Christine Sedlik1, Pamela Caudana1, Fiorella Kotsias1, Leticia L Niborski1, Sophie Viel1, Mylène Bohec5, Sonia Lameiras5, Sylvain Baulande5, Laëtitia Lesage6, André Nicolas6, Didier Meseure6, Anne Vincent-Salomon6, Fabien Reyal7, Charles-Antoine Dutertre8, Florent Ginhoux9, Lene Vimeux10, Emmanuel Donnadieu10, Bénédicte Buttard11, Jérôme Galon11, Santiago Zelenay2, William Vermi12, Pierre Guermonprez13, Eliane Piaggio1, Julie Helft14.   

Abstract

Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration correlates with lower patient survival and resistance to therapy. Tumor-associated macrophages, however, are phenotypically and functionally heterogeneous. Specific subsets of tumor-associated macrophage might be endowed with distinct roles on cancer progression and antitumor immunity. Here, we identify a discrete population of FOLR2+ tissue-resident macrophages in healthy mammary gland and breast cancer primary tumors. FOLR2+ macrophages localize in perivascular areas in the tumor stroma, where they interact with CD8+ T cells. FOLR2+ macrophages efficiently prime effector CD8+ T cells ex vivo. The density of FOLR2+ macrophages in tumors positively correlates with better patient survival. This study highlights specific roles for tumor-associated macrophage subsets and paves the way for subset-targeted therapeutic interventions in macrophages-based cancer therapies.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8(+) T lymphocytes; FOLR2; TREM2; breast cancer; single-cell RNA sequencing; tissue-resident macrophages

Mesh:

Substances:

Year:  2022        PMID: 35325594     DOI: 10.1016/j.cell.2022.02.021

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  9 in total

Review 1.  The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.

Authors:  Xingxing Zhang; Wenxiu Bai; Lisha Hu; Hualan Ha; Yuelin Du; Wei Xiong; Hongbo Wang; Panfeng Shang
Journal:  Clin Transl Oncol       Date:  2022-09-07       Impact factor: 3.340

2.  Novel paradigms of macrophage biology and function: identification of disease biomarkers and therapeutic targets.

Authors:  Diane Catherine Wang; Xuanqi Liu; Charles A Powell; Xiangdong Wang
Journal:  Cell Biol Toxicol       Date:  2022-07-18       Impact factor: 6.819

Review 3.  Exploring the Impact of TREM2 in Tumor-Associated Macrophages.

Authors:  Darya Khantakova; Simone Brioschi; Martina Molgora
Journal:  Vaccines (Basel)       Date:  2022-06-14

Review 4.  The pleiotropic roles of adipocyte secretome in remodeling breast cancer.

Authors:  Xiaomei Zhou; Jun Zhang; Wenchang Lv; Chongru Zhao; Yu Xia; Yiping Wu; Qi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

5.  Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration.

Authors:  Jiafa Wu; Dongping Luo; Shengnan Li
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-08-15

Review 6.  The therapeutic potential of TREM2 in cancer.

Authors:  Elysa M Wolf; Barbara Fingleton; Alyssa H Hasty
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

7.  Identification of Immune Cell Components in Breast Tissues by a Multiparametric Flow Cytometry Approach.

Authors:  Luigi Coppola; Giovanni Smaldone; Massimiliano D'aiuto; Giuseppe D'aiuto; Gennaro Mossetti; Massimo Rinaldo; Simona Verticilo; Emanuele Nicolai; Marco Salvatore; Peppino Mirabelli
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

Review 8.  Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer.

Authors:  Davide Massa; Anna Tosi; Antonio Rosato; Valentina Guarneri; Maria Vittoria Dieci
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

9.  Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers.

Authors:  Xiaoyu Liu; Xu Xu; Zhuozhuo Wu; Qungang Shan; Ziyin Wang; Zhiyuan Wu; Xiaoyi Ding; Wei Huang; Zhongmin Wang
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.